Results 91 to 100 of about 2,219,836 (309)

Five‐Year Outcomes of Laparoscopic Sphincter‐Preserving Surgery for Rectal Cancer: A Prospective Study in Elderly Vietnamese Patients

Aging and Cancer, EarlyView.
This prospective study demonstrates that laparoscopic sphincter‐preserving surgery is feasible for elderly patients. While overall survival reaches 70% at 5 years, advanced T‐stage and the omission of neoadjuvant therapy significantly drive recurrence, highlighting the need for personalized geriatric protocols despite logistical challenges.
Huu Duc Ho, Quang Le, Ngoc Thach Tran, Van Viet Ung, Loc Vu   +4 more
wiley   +1 more source

Do Renal Tumor Characteristics Affect the Number of Hemostatic Agents Used During Partial Nephrectomy?

, 2019
Objective:The aim of this study was to investigate the use and types of hemostatic agents (HAs) used during partial nephrectomy (PN) and the relationship of the number of these agents used during surgery with tumor size, RENAL nephrometry score (NS ...
Hilal Şahin, Yusuf Özlem İlbey, Mehmet Yiğit Yalçın, Erdem Kısa, Cem Yücel, Mehmet Zeynel Keskin, Özgür Çakmak   +6 more
core   +1 more source

Acute Kidney Injury After Mechanical Thrombectomy for Stroke in Patients With Pre‐Existing Renal Impairment

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Acute kidney injury (AKI) is a common but often underrecognized complication in ischemic stroke patients undergoing mechanical thrombectomy, particularly among those with pre‐existing renal impairment. This study evaluated the incidence, risk factors, and clinical impact of AKI in this high‐risk population.
Michał Borończyk, Marcel Pilarek, Emilia Jaworska, Natalia Kardas, Oliwia Barnaś, Julia Woźniak, Iga Machała, Julia Węgrzynek‐Gallina, Joanna Siuda, Anna Hawrot‐Kawecka, Anetta Lasek‐Bal   +10 more
wiley   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley   +1 more source

Handling and staging of renal cell carcinoma the international society of urological pathology consensus (ISUP) conference recommendations

, 2013
The International Society of Urologic Pathology 2012 Consensus Conference on renal cancer, through working group 3, focused on the issues of staging and specimen handling of renal tumors.
Martignoni G., Evans A., Montironi, Rodolfo, Bonsib, S.M., Rezaei K., Bonsib, Stephen M., Fajardo D., Cathro H., Lloreta J., Amin, Mahul B, Gupta N., Kida M., Grignon D. J., Shanks J., Srinivasan B., Griffiths D., Latour M., Montironi, R., Humphrey P., Abraham A., Nichols P., Osunkoya A., Delahunt, B, Murphy H., Grignon D.J., Pyda-Karwicka M., Van Der Kwast T., Fine S., Kristiansen G., Warren A., Delahunt B., Falzarano S., Tamboli P., Srigley, John R., Billis, A., Bostwick D., Ronchetti R., Iczkowski K., Trias I., Allan R., ,, Kench J., Nazeer T., Billis, Athanase, Hulsbergen-van de Kaa, C.A., Deng F.-M., Chen Y.-B., Samaratunga, H, Lopez-Beltran, A., the ISUP Renal Tumor Panel, Trpkov, K., Zhao J., Hirsch M., Amin, Mahul B., Tan P.H., Amin M. B., Bethwaite P., Egevad, Lars, Reuter V., Egevad, L., Lopez-Beltran, Antonio, Egevad, L,, Srigley J.R., Jones E., Lewin C., Sweet J., Argani P., Suzigan S., Ghayouri M., Lie K., Russell L., Nesi G., Vakar-Lopez F., Tickoo S., Srigley J. R., McHale T., Shen S., Tamboli, Pheroze, Cheville J., Wang C., Grignon, David J, Rioux-Leclercq N., Lopez Beltran A., Tamboli, P., Giannico G., Ahmed K., Shabaik A., Jufe L.I., Billis, A, Bonsib, Stephen M, Samaratunga H., Amin, MB, Huang W., Brimo F., Axcrona U., Petraki C., Tamboli, P, Gokden N., Samaratunga, H., Hes O., Shevchuk M., Hussein S., Maclean F., the members of the ISUP Renal Tumor Panel, Miller R., Billis A., Zynger D., Yilmaz A., Parwani A., Birbe R., Loftus B., Lopez-Beltran, A, Bonsib S.M., Perry-Keene J., Amin, M.B., Miyamoto H., Al Ahmadie H., Crist H., Hameed O., Cheng L., Ganji M., Robinson B., True L., Pan C.-C., Picken M., Adeniran A., Berney D., Egevad L., Nacey J., Epstein J., Montironi R., Ozagari A., Samaratunga, Hemamali, Moch H., Bonsib S. M., Fridman E., Lane Z., Furusato B., Rohan S., Bonsib, SM, Barry M., Baydar D., Tsuzuki T., Delahunt, B., Cohen C., Kunju L.P., et al., Cho Y.M., Magi-Galluzzi C., Shah R., Delprado W., Fadare O., Huang J., Grignon, David J., Olgac S., Trpkov, K, Jimenez R., Sibony M., Srigley, John R, Merino M., Chuang A.-Y., Netto G., Zhou M., McKenney J., Takahashi H., Srigley, J.R., Van De Kaa C.H., Orozco R., Trpkov, Kiril, Scarpelli M., Yao J., Delahunt, Brett, Amin M.B., Grignon, DJ, Begin L., Algaba F., Fleming S., O'Donnell M., Susani M., Grignon, D.J., Lopez-Beltran A., Trpkov K.   +181 more
core   +1 more source

Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer [PDF]

, 2008
Background Enhanced activity of histone deacetylases (HDAC) is associated with more aggressive tumour behaviour and tumour progression in various solid tumours.
Dietel Manfred, Fritzsche, Florian R., Weichert Wilko, Gekeler Volker, Dietel, Manfred, Fritzsche Florian R, Beckers Thomas, Kristiansen Glen, Jung, Klaus, Kristiansen, Glen, Weichert, Wilko, Jung Klaus, Scholman Katharina, Gekeler, Volker, Denkert Carsten, Röske, Annika, Röske Annika, Beckers, Thomas, Stephan, Carsten, Stephan Carsten, Scholman, Katharina, Denkert, Carsten Michael   +21 more
core   +1 more source

Assessing the Sensitivity and the Clinical Impact of the 2023 American College of Rheumatology/EULAR Classification Criteria in Obstetric Antiphospholid Syndrome: Findings From a Multicenter Italian Cohort With a Long‐Term Follow‐Up

Arthritis Care &Research, EarlyView.
Objective The aim of this study was to evaluate the sensitivity of the 2023 American College of Rheumatology (ACR)/EULAR classification criteria for antiphospholipid syndrome (APS) in a real‐world cohort of women diagnosed with primary obstetric APS (oAPS) and to assess their ability to identify patients at risk of future pregnancy complications ...
Francesca Ruffilli, Cecilia Nalli, Francesca Crisafulli, Carlo Garaffoni, Marcello Govoni, Giulia Voltarel, Alba C. Pozzi, Beatrice Maranini, Ettore Silvagni, Alessandra Bortoluzzi, Angela Tincani   +10 more
wiley   +1 more source

Renal pericytes: regulators of medullary blood flow [PDF]

, 2012
Regulation of medullary blood flow (MBF) is essential in maintaining normal kidney function. Blood flow to the medulla is supplied by the descending vasa recta (DVR), which arise from the efferent arterioles of juxtamedullary glomeruli.
Peppiatt-Wildman, Claire M., Kennedy-Lydon, T M, Wildman, S S P, Peppiatt-Wildman, C M, Peppiatt‐Wildman, C. M., Kennedy‐Lydon, T. M., Wildman, Scott S.P., Kennedy-Lydon, T. M., Crawford, C., Crawford, C, Wildman, S. S. P.   +10 more
core   +1 more source

Embolization of renal tumor bone metastasis: case report. [PDF]

J Vasc Bras, 2021
Ribeiro FS, Jeha SAH, Dos Santos JVF, Damasceno AVSB, da Silva TMMF, do Couto FB, Reale HB.   +6 more
europepmc   +1 more source

The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo [PDF]

, 2008
Histone deacetylase (HDAC) inhibitors represent a promising class of antineoplastic agents which affect tumour growth, differentiation and invasion. The effects of the HDAC inhibitor valproic acid (VPA) were tested in vitro and in vivo on pre-clinical ...
Eva Juengel, Mickuckyte, Ausra, Hudak, Lukasz, Jones, Jon, Lukasz Hudak, Jüngel, Eva, Dietger Jonas, Blaheta, Roman A., Roman A. Blaheta, Wedel, Steffen Alexander, Ausra Mickuckyte, Jonas, Dietger, Jon Jones, Steffen Wedel   +13 more
core   +1 more source